So it also seems that the 7.1 quarters doesn't factor in the reserve they are required hold, no?
A cap raise is absolutely needed soon, but they're being awfully evasive about their financial position.
They've spent a large amount of money to simply begin recruitment for a study, and resubmit an application for approval IMO.
I'd be unhappy as well, though this isn't unexpected to be honest.
Fingers crossed for approval, that's the only thing that matters, there likely won't be a fourth shot.
- Forums
- ASX - By Stock
- MSB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-22
-
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
0.018(1.16%) |
Mkt cap ! $1.712B |
Open | High | Low | Value | Volume |
$1.50 | $1.54 | $1.48 | $4.226M | 2.811M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 56729 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.54 | 14401 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 58048 | 1.530 |
18 | 61101 | 1.525 |
5 | 17736 | 1.520 |
8 | 27327 | 1.515 |
19 | 138125 | 1.510 |
Price($) | Vol. | No. |
---|---|---|
1.535 | 14622 | 6 |
1.540 | 121228 | 14 |
1.545 | 131972 | 7 |
1.550 | 169363 | 26 |
1.555 | 1722 | 2 |
Last trade - 14.39pm 13/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online